NCT02434354 Neoadjuvant anti-PD-1 Pembrolizumab Clinical Trial
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Flow cytometry data for NCT02434354 Neoadjuvant anti-PD-1 Pembrolizumab Clinical Trial. Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with pathologic response to neoadjuvant anti-PD-1 therapy Cancer Cell 2025
创建时间：
2025-12-08
